Decision Resources acquires Manhattan Research

Share this article:

Decision Resources announced the acquisition of Manhattan Research on June 17.  The move will expand Decision Resources' global physician and consumer digital market research portfolio, according to a statement.  Terms of the deal were not disclosed to the public.

“Part of Decision Resources' big goal is to grow our business both organically, and to build a stable of premier market research firms that focus on specific areas of the healthcare industry,” said Elizabeth Marshall, director of marketing at Decision Resources.  Marshall cites Millennium Research Group and HealthLeaders as two examples of other research firms providing Decision Resources with a specialized focus: Millennium for medical devices and technology, and HealthLeaders for managed care.  “We're looking at the bigger picture and the healthcare industry as a whole – we're offering clients an integrated model,” says Marshall.  

Manhattan Research will remain headquartered in New York, NY.  Decision Resources is located in Waltham, MA.  Other companies owned by Decision Resources include Arlington Medical Resources, which was acquired last December, and Fingertip Formulary, acquired in March. 

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.